Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Trang Ly, MBBS, FRACP, PhD, the senior vice president and medical director at Insulet Corp., sat with MD Magto talk about the new additions to the Omnipod DASH insulin management system, which were presented in a product theater at the American Diabetes Association's 78th Annual Scientific Session in Orlando, Florida. Data from a clinical trial of the product was also presented at the conference.
That study, of 11 adults aged 18-65 years with type 1 diabetes, took place over a 5-day period in a supervised hotel setting with free-living conditions. The average hemoglobin A1C of the group was 7.4%, with participants administering a mean dose of 0.67 U/kg of insulin daily. Patients meals were unrestricted, and exercise of moderate intensity was performed for 30 minutes daily.
http://www.mdmag.com/conference-cov...system-shows-improved-glycemic-control-in-t1d
That study, of 11 adults aged 18-65 years with type 1 diabetes, took place over a 5-day period in a supervised hotel setting with free-living conditions. The average hemoglobin A1C of the group was 7.4%, with participants administering a mean dose of 0.67 U/kg of insulin daily. Patients meals were unrestricted, and exercise of moderate intensity was performed for 30 minutes daily.
http://www.mdmag.com/conference-cov...system-shows-improved-glycemic-control-in-t1d
